Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome.
Chunyan GuCarol HolmanRamakrishna SompallaeXuefang JingMichael TomassonDirk HoseAnja SeckingerFenghuang ZhanGuido TricotHartmut GoldschmidtYe YangSiegfried JanzPublished in: Blood cancer journal (2018)